ATHENA (GOG-3020/ENGOT-ov45): a randomized, double-blind, placebo-controlled, Phase III study of rucaparib plus nivolumab following front-line platinum-based chemotherapy in ovarian cancer

被引：5

作者：

Westin, Shannon N. ^{[1
]}

Kristeleit, Rebecca S. ^{[2
]}

Coleman, Robert L. ^{[1
]}

Fujiwara, Keiichi ^{[3
]}

Oza, Amit M. ^{[4
]}

O'Malley, David M. ^{[5
]}

Herzog, Thomas J. ^{[6
]}

Marme, Frederik ^{[7
]}

Oaknin, Ana ^{[8
]}

Eskander, Ramez ^{[9
]}

Lorusso, Domenica ^{[10
,11
]}

Safra, Tamar ^{[12
]}

Korach, Jacob ^{[13
]}

Lin, Kevin K. ^{[14
]}

Shih, Danny ^{[14
]}

Caunt, Lisa ^{[14
]}

Goble, Sandra ^{[14
]}

Hume, Stephanie ^{[14
]}

Maloney, Lara ^{[14
]}

McNeish, Iain ^{[15
]}

Monk, Bradley J. ^{[16
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] UCL, Inst Canc, London, England

[3] Saitama Med Univ, Int Med Ctr, Hidaka, Saitama, Japan

[4] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada

[5] Ohio State Univ, James Canc Ctr, Columbus, OH 43210 USA

[6] Univ Cincinnati, Inst Canc, Cincinnati, OH USA

[7] Natl Ctr Tumor Dis NCT Heidelberg, Gynakol Onkol, Heidelberg, Germany

[8] Vall dHebron Univ Hosp Vall, Vall dHebron Inst Oncol VHIO, Barcelona, Spain

[9] Univ Calif San Diego, Rebecca & John Moores Canc Ctr, La Jolla, CA 92093 USA

[10] Fdn IRCCS Ist Nazl Tumori, Milan, Italy

[11] MITO, Milan, Italy

[12] Sourasky Med Ctr, Tel Aviv, Israel

[13] Sheba Med Ctr, Tel Hashomer, Israel

[14] Clovis Oncol Inc, Boulder, CO USA

[15] Imperial Coll London, London, England

[16] Creighton Univ, Sch Med, Univ Arizona, Arizona Oncol US Oncol Network,Coll Med, Phoenix, AZ USA

来源：

CANCER RESEARCH | 2019年 / 79卷 / 13期

关键词：

D O I：

10.1158/1538-7445.AM2019-CT158

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CT158

引用

页数：3